ArticleJournal of thoracic disease2020

Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Mike Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.